Epigral Limited (NSE:EPIGRAL)

Market Cap	48.76B -37.9%
Revenue (ttm)	25.27B -0.9%
Net Income	3.32B -7.2%
EPS	76.95 -9.1%
Shares Out	43.14M
PE Ratio	14.69
Forward PE	12.05
Dividend	5.00 (0.44%)
Ex-Dividend Date	Jun 1, 2026

Volume	20,860
Open	1,140.00
Previous Close	1,139.50
Day's Range	1,116.00 - 1,147.30
52-Week Range	807.00 - 2,114.00
Beta	0.23
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 30, 2026

About Epigral

Epigral Limited manufactures and sells chlor-alkali and derivative products in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resin, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power plant. Its products are used in CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agrochemicals, pharm...

• Industry: Chemicals
• Sector: Materials
• Founded: 2007
• Employees: 1,072
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: EPIGRAL

Financial Performance

In fiscal year 2026, Epigral's revenue was 25.27 billion, a decrease of -0.90% compared to the previous year's 25.50 billion. Earnings were 3.32 billion, a decrease of -7.19%.